ivabradine has been researched along with Coxsackie Virus Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jia-Feng, L; Li-Sha, G; Na-Dan, Z; Qin, L; Teng, Z; Xue-Qiang, G; Yue-Chun, L | 1 |
| Chen, YH; Ge, LS; Guan, XQ; Li, YC; Lin, JF; Luo, Q; Zhang, T; Zhou, ND | 1 |
2 other study(ies) available for ivabradine and Coxsackie Virus Infections
| Article | Year |
|---|---|
Comparison of effects of ivabradine versus carvedilol in murine model with the Coxsackievirus B3-induced viral myocarditis.
Topics: Adrenergic beta-Antagonists; Animals; Apoptosis; Benzazepines; Carbazoles; Carvedilol; Coxsackievirus Infections; Cytokines; Disease Models, Animal; Enterovirus B, Human; Heart; Heart Rate; Ivabradine; Male; Mice; Myocardial Contraction; Myocarditis; Myocardium; Oxidative Stress; Propanolamines | 2012 |
Ivabradine inhibits the production of proinflammatory cytokines and inducible nitric oxide synthase in acute coxsackievirus B3-induced myocarditis.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Benzazepines; Carbazoles; Carvedilol; Coxsackievirus Infections; Cytokines; Gene Expression; Ivabradine; Male; Mice; Mice, Inbred BALB C; Myocarditis; Nitric Oxide; Nitric Oxide Synthase Type II; Propanolamines | 2013 |